Page last updated: 2024-11-04

ropinirole and Cholera Infantum

ropinirole has been researched along with Cholera Infantum in 2 studies

Research Excerpts

ExcerptRelevanceReference
" The objective of this study was to perform an indirect comparison of Adverse Events (AEs) and Dropout Rates (DRs) among clinical trials of pramipexole, ropinirole, and rasagiline."2.48Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline. ( Tarrants, ML; Zagmutt, FJ, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HJ1
Park, SY1
Cho, YJ1
Hong, KS1
Cho, JY1
Seo, SY1
Lee, DH1
Jeon, BS1
Zagmutt, FJ1
Tarrants, ML1

Reviews

1 review available for ropinirole and Cholera Infantum

ArticleYear
Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline.
    The International journal of neuroscience, 2012, Volume: 122, Issue:7

    Topics: Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cross-Sectional Studies; Databases, Bibli

2012

Other Studies

1 other study available for ropinirole and Cholera Infantum

ArticleYear
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
    Journal of the neurological sciences, 2009, Dec-15, Volume: 287, Issue:1-2

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation;

2009